Literature DB >> 17889260

Wegener granulomatosis with spleen infarction: case report and review of the literature.

Alessandra Ghinoi1, Nicolò Pipitone, Alberto Cavazza, Luigi Boiardi, Carlo Salvarani.   

Abstract

OBJECTIVE: To report a case of biopsy-verified Wegener granulomatosis (WG) with positive c-antineutrophil cytoplasmic antibodies who had evidence of spleen infarction and to review the relevant literature on spleen involvement in WG.
METHODS: Descriptive case report of 1 patient with WG complicated by spleen infarction and review of the relevant literature (PubMed search 1966 through February 2007).
RESULTS: In our patient spleen involvement (infarction) was clinically silent and was incidentally detected on the caudal slides of a chest computed tomography (CT) performed to investigate pulmonary involvement. Similar cases have been reported: in the published literature reviewed, overall 18 patients have been described and other cases have been described after autopsy. Of these, 8 patients were symptomatic: generally, they complained of diffuse or left upper quadrant abdominal pain. In 15 patients, spleen involvement was detected by ultrasound, scintigraphy, CT scan, or magnetic resonance imaging. In 1 case only was the diagnosis confirmed by biopsy (after splenectomy).
CONCLUSIONS: The frequency of spleen infarction is probably underestimated in WG since it is often clinically silent as in our patient. In addition to spleen infarction, WG has also been implicated in inducing spleen hemorrhage, capsular adhesions, dysfunction, and splenomegaly. Since some of the spleen lesions may lead to complications, a high index of suspicion should be maintained for spleen involvement in patients with WG, particularly in the presence of abdominal symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17889260     DOI: 10.1016/j.semarthrit.2007.07.009

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  8 in total

1.  Cytomegalovirus Disease in a Patient With Granulomatosis With Polyangiitis Who Also Has Splenic Necrosis.

Authors:  Önay Gerçik; Dilek Solmaz; Şebnem Karasu; Neşe Ekinci; Servet Akar
Journal:  Arch Rheumatol       Date:  2019-04-22       Impact factor: 1.472

2.  Asymptomatic appearance of splenic infarction in Wegener's granulomatosis.

Authors:  Magdalena Martusewicz-Boros; Inga Baranska; Elzbieta Wiatr; Iwona Bestry; Kazimierz Roszkowski-Sliz
Journal:  Pol J Radiol       Date:  2011-04

Review 3.  PR3 vasculitis presenting with symptomatic splenic and renal infarction: a case report and literature review.

Authors:  M J Bottomley; M Gibson; B Alchi
Journal:  BMC Nephrol       Date:  2019-03-06       Impact factor: 2.388

Review 4.  Antineutrophil cytoplasmic antibody-positive infective endocarditis complicated by acute kidney injury: a case report and literature review.

Authors:  Wei Zhang; Hui Zhang; Daoxu Wu; Haiyang Fu; Weiping Shi; Feng Xue
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

5.  Granulomatosis with polyangiitis (Wegener's) complicated by splenic rupture and severe acute respiratory distress syndrome: A case report.

Authors:  Yannis Ahmad; Gabrielle Morawietz; Hatem Ksouri; Joerg C Schefold; Patrick Zuercher
Journal:  Clin Case Rep       Date:  2021-07-09

6.  Initial diagnosis of Wegener's granulomatosis mimicking severe ulcerative colitis: a case report.

Authors:  Sonja Timmermann; Alberto Perez Bouza; Karsten Junge; Ulf P Neumann; Marcel Binnebösel
Journal:  J Med Case Rep       Date:  2013-05-29

7.  Diffuse Large B Cell Lymphoma Mimicking Granulomatosis with Polyangiitis.

Authors:  Mohammad E Naffaa; Alexander P Rozin; Netanel Horowitz; Ofer Ben-Itzhak; Yolanda Braun-Moscovici; Alexandra Balbir-Gurman
Journal:  Case Rep Rheumatol       Date:  2016-05-18

8.  Antineutrophil Cytoplasmic Antibodies Associated With Infective Endocarditis.

Authors:  Vincent Langlois; Anais Lesourd; Nicolas Girszyn; Jean-Francois Ménard; Hervé Levesque; Francois Caron; Isabelle Marie
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.